psychoeducation

Patients

After a schizophrenia diagnosis, families must learn how to navigate treatment, respond to symptoms, and communicate effectively.

News

Acadia Pharmaceuticals has secured EC approval for DAYBU (trofinetide) for the neurobehavioural symptoms of Rett syndrome in the EU.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.